These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33745265)
1. Interaction between LINC-ROR and Stemness State in Gastric Cancer Cells with Helicobacter pylori Infection. Alsadat Mahmoudian R; Lotfi Gharaie M; Abbaszadegan R; Forghanifard MM; Abbaszadegan MR Iran Biomed J; 2021 Mar; 25(3):157-68. PubMed ID: 33745265 [TBL] [Abstract][Full Text] [Related]
2. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer]. Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128 [No Abstract] [Full Text] [Related]
3. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value. Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123 [TBL] [Abstract][Full Text] [Related]
4. Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma. Fawzy MS; Toraih EA; El-Wazir A; Hosny MM; Badran DI; El Kelish A Arch Med Sci; 2021; 17(4):1016-1027. PubMed ID: 34336029 [TBL] [Abstract][Full Text] [Related]
5. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition. Liu M; Zhang M; Yin H Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480 [TBL] [Abstract][Full Text] [Related]
6. Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma. Sahebi R; Malakootian M; Balalaee B; Shahryari A; Khoshnia M; Abbaszadegan MR; Moradi A; Javad Mowla S Iran J Basic Med Sci; 2016 Oct; 19(10):1131-1135. PubMed ID: 27872710 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of LINC-ROR in cancer cell lines and tissues. Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression. Qu CH; Sun QY; Zhang FM; Jia YM Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092 [TBL] [Abstract][Full Text] [Related]
9. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma. Toraih EA; El-Wazir A; Hussein MH; Khashana MS; Matter A; Fawzy MS; Hosny S Int J Biol Markers; 2019 Mar; 34(1):69-79. PubMed ID: 30852975 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of Linc-ROR Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells Through miR-212-3p/FGF7 Axis. Mi Y; Li Y; He Z; Chen D; Hong Q; You J Cancer Manag Res; 2021; 13():899-912. PubMed ID: 33564265 [TBL] [Abstract][Full Text] [Related]
11. Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9. Wang L; Yu X; Zhang Z; Pang L; Xu J; Jiang J; Liang W; Chai Y; Hou J; Li F J Exp Clin Cancer Res; 2017 Dec; 36(1):182. PubMed ID: 29237490 [TBL] [Abstract][Full Text] [Related]
12. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Fu Z; Li G; Li Z; Wang Y; Zhao Y; Zheng S; Ye H; Luo Y; Zhao X; Wei L; Liu Y; Lin Q; Zhou Q; Chen R Cell Death Discov; 2017; 3():17004. PubMed ID: 28580169 [TBL] [Abstract][Full Text] [Related]
14. The roles of Linc-ROR in the regulation of cancer stem cells. Wen X; Wu Y; Lou Y; Xia Y; Yu X Transl Oncol; 2023 Feb; 28():101602. PubMed ID: 36535192 [TBL] [Abstract][Full Text] [Related]
15. The Long Non-Coding RNA-RoR Promotes the Tumorigenesis of Human Colorectal Cancer by Targeting miR-6833-3p Through SMC4. Li X; Chen W; Jia J; You Z; Hu C; Zhuang Y; Lin Z; Liu Y; Yang C; Xu R Onco Targets Ther; 2020; 13():2573-2581. PubMed ID: 32273727 [TBL] [Abstract][Full Text] [Related]
16. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells. Chen YM; Liu Y; Wei HY; Lv KZ; Fu P Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251 [TBL] [Abstract][Full Text] [Related]
17. Differential Expression Pattern of linc-ROR Spliced Variants in Pluripotent and Non-Pluripotent Cell Lines. Mirzadeh Azad F; Taheri Bajgan E; Naeli P; Rudov A; Bagheri Moghadam M; Sadat Akhtar M; Gholipour A; Mowla SJ; Malakootian M Cell J; 2022 Oct; 24(10):569-576. PubMed ID: 36259474 [TBL] [Abstract][Full Text] [Related]
18. Linc-ROR Regulates Yu X; Ma X; Jia Y; Wu X; Yan Z Cell Transplant; 2023; 32():9636897231178902. PubMed ID: 37306240 [TBL] [Abstract][Full Text] [Related]
19. Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling. Lou Y; Jiang H; Cui Z; Wang L; Wang X; Tian T Oncotarget; 2017 Sep; 8(41):69983-69994. PubMed ID: 29050257 [TBL] [Abstract][Full Text] [Related]
20. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway. Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]